Product Code: ETC067018 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Saudi Arabia non-oncology precision medicine market has been growing due to advancements in genomics, molecular diagnostics, and personalized medicine approaches. Non-oncology precision medicine aims to improve patient outcomes by identifying individualized treatment options, predicting disease risks, and optimizing therapy based on an individual`s unique characteristics.
Saudi Arabia is witnessing an increase in chronic diseases such as cardiovascular diseases, diabetes, and neurodegenerative disorders. Non-oncology precision medicine offers the potential to enhance disease management and treatment outcomes in these conditions. The progress in genomics research and the availability of advanced diagnostic tools have expanded the scope of non-oncology precision medicine. Genetic testing, molecular diagnostics, and biomarker discovery contribute to personalized treatment approaches. The Saudi Arabia government has prioritized healthcare improvements and initiatives, including precision medicine. Investments in infrastructure, research, and healthcare technologies drive the market for non-oncology precision medicine.
Widespread adoption and implementation of non-oncology precision medicine practices require changes in healthcare systems, including training healthcare professionals, integrating genetic testing, and incorporating personalized treatment approaches into routine care. Precision medicine relies on the collection and analysis of individuals` genetic and health data. Protecting patient privacy, ensuring data security, and addressing ethical concerns related to genetic testing and data use pose challenges to the market.
The Covid-19 pandemic has significantly impacted the healthcare landscape globally, including the field of precision medicine. While the pandemic`s primary focus has been on managing and mitigating the immediate health crisis, the importance of precision medicine in understanding genetic susceptibility and developing targeted therapies has been highlighted. The pandemic may have indirectly impacted the non-oncology precision medicine market through resource allocation and shifting priorities in healthcare systems.
Some key players in the Saudi Arabia non-oncology precision medicine market include, Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., and Abbott Laboratories.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Non-Oncology Precision Medicine Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Saudi Arabia Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Saudi Arabia Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Saudi Arabia Non-Oncology Precision Medicine Market Trends |
6 Saudi Arabia Non-Oncology Precision Medicine Market, By Types |
6.1 Saudi Arabia Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2031F |
6.1.3 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2031F |
6.1.4 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2031F |
6.1.5 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2031F |
6.1.6 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2031F |
6.1.7 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 Saudi Arabia Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2031F |
6.2.3 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2031F |
6.2.4 Saudi Arabia Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2031F |
7 Saudi Arabia Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Saudi Arabia Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Saudi Arabia Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Saudi Arabia Non-Oncology Precision Medicine Market Key Performance Indicators |
9 Saudi Arabia Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Saudi Arabia Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Saudi Arabia Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Saudi Arabia Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Saudi Arabia Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |